Work

Abstract PS5-01-10: Estimating the effect of initiating early maintenance endocrine therapy on brain metastases-free survival and other clinical outcomes in patients with HER2+/HR+ mBC without brain metastases: A target trial emulation

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-01-10

Authors: T. Sanglier, I. Gravestock, J. Leone, M. Secrest, C. Tchakoute, E. Restuccia, F. Montemurro, M. Shivhare, A. Knott, P. Lambert, D. Martinez, P. Luhn, X. Garcia de Albeniz Martinez, S. Tolaney, N. Lin, S. Sammons

Institutions: Roche (Switzerland), Dana-Farber Cancer Institute, Genentech, Roche (United Kingdom), RTI Health Solutions

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129612717

Cites:

Cited by:

Related to: